nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—ABCB1—Liothyronine—hypothyroidism	0.144	0.28	CbGbCtD
Mifepristone—ABCB1—Levothyroxine—hypothyroidism	0.144	0.28	CbGbCtD
Mifepristone—ABCB1—Liotrix—hypothyroidism	0.14	0.273	CbGbCtD
Mifepristone—CYP3A4—Levothyroxine—hypothyroidism	0.086	0.168	CbGbCtD
Mifepristone—PGR—corpus luteum—hypothyroidism	0.0396	0.199	CbGeAlD
Mifepristone—AR—seminiferous tubule of testis—hypothyroidism	0.0267	0.134	CbGeAlD
Mifepristone—NR3C1—urine—hypothyroidism	0.00747	0.0376	CbGeAlD
Mifepristone—PGR—Nuclear Receptors—THRA—hypothyroidism	0.00706	0.0667	CbGpPWpGaD
Mifepristone—Hypertension—Liothyronine—hypothyroidism	0.00581	0.032	CcSEcCtD
Mifepristone—CYP3A4—urine—hypothyroidism	0.00565	0.0284	CbGeAlD
Mifepristone—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.00562	0.0309	CcSEcCtD
Mifepristone—Hypoglycaemia—Levothyroxine—hypothyroidism	0.00562	0.0309	CcSEcCtD
Mifepristone—PGR—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00558	0.0527	CbGpPWpGaD
Mifepristone—CYP2D6—urine—hypothyroidism	0.00556	0.028	CbGeAlD
Mifepristone—AR—Nongenotropic Androgen signaling—SHBG—hypothyroidism	0.00539	0.0508	CbGpPWpGaD
Mifepristone—AR—Nuclear Receptors—THRA—hypothyroidism	0.00538	0.0508	CbGpPWpGaD
Mifepristone—NR3C1—nerve—hypothyroidism	0.00515	0.0259	CbGeAlD
Mifepristone—Hypotension—Liothyronine—hypothyroidism	0.00513	0.0282	CcSEcCtD
Mifepristone—Muscular weakness—Levothyroxine—hypothyroidism	0.00484	0.0266	CcSEcCtD
Mifepristone—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00484	0.0266	CcSEcCtD
Mifepristone—PGR—Nuclear Receptors—THRB—hypothyroidism	0.00455	0.043	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—POU1F1—hypothyroidism	0.00452	0.0426	CbGpPWpGaD
Mifepristone—Body temperature increased—Liothyronine—hypothyroidism	0.00434	0.0239	CcSEcCtD
Mifepristone—AR—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00425	0.0401	CbGpPWpGaD
Mifepristone—Hypoglycaemia—Liotrix—hypothyroidism	0.00414	0.0228	CcSEcCtD
Mifepristone—NR3C1—Nuclear Receptors—THRA—hypothyroidism	0.00408	0.0385	CbGpPWpGaD
Mifepristone—Hypokalaemia—Liotrix—hypothyroidism	0.00367	0.0202	CcSEcCtD
Mifepristone—PGR—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.0036	0.0339	CbGpPWpGaD
Mifepristone—Muscular weakness—Liotrix—hypothyroidism	0.00356	0.0196	CcSEcCtD
Mifepristone—AR—Nuclear Receptors—THRB—hypothyroidism	0.00347	0.0327	CbGpPWpGaD
Mifepristone—PGR—heart—hypothyroidism	0.00332	0.0167	CbGeAlD
Mifepristone—NR3C1—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00323	0.0305	CbGpPWpGaD
Mifepristone—CYP3A7—liver—hypothyroidism	0.0032	0.0161	CbGeAlD
Mifepristone—PGR—cardiovascular system—hypothyroidism	0.00313	0.0157	CbGeAlD
Mifepristone—Angioedema—Dextrothyroxine—hypothyroidism	0.00302	0.0166	CcSEcCtD
Mifepristone—Angioedema—Levothyroxine—hypothyroidism	0.00302	0.0166	CcSEcCtD
Mifepristone—Arthralgia—Levothyroxine—hypothyroidism	0.00281	0.0155	CcSEcCtD
Mifepristone—Arthralgia—Dextrothyroxine—hypothyroidism	0.00281	0.0155	CcSEcCtD
Mifepristone—Anxiety—Levothyroxine—hypothyroidism	0.0028	0.0154	CcSEcCtD
Mifepristone—Anxiety—Dextrothyroxine—hypothyroidism	0.0028	0.0154	CcSEcCtD
Mifepristone—PGR—pituitary gland—hypothyroidism	0.00277	0.0139	CbGeAlD
Mifepristone—AR—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00274	0.0259	CbGpPWpGaD
Mifepristone—AR—adrenal cortex—hypothyroidism	0.00273	0.0137	CbGeAlD
Mifepristone—CYP3A7-CYP3A51P—liver—hypothyroidism	0.00272	0.0137	CbGeAlD
Mifepristone—AR—heart—hypothyroidism	0.00264	0.0133	CbGeAlD
Mifepristone—NR3C1—Nuclear Receptors—THRB—hypothyroidism	0.00263	0.0248	CbGpPWpGaD
Mifepristone—ABCC1—adrenal cortex—hypothyroidism	0.0026	0.0131	CbGeAlD
Mifepristone—ABCC1—heart—hypothyroidism	0.00251	0.0126	CbGeAlD
Mifepristone—AR—cardiovascular system—hypothyroidism	0.00249	0.0125	CbGeAlD
Mifepristone—PGR—adrenal gland—hypothyroidism	0.00248	0.0124	CbGeAlD
Mifepristone—PGR—blood—hypothyroidism	0.00248	0.0124	CbGeAlD
Mifepristone—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00246	0.0135	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00246	0.0135	CcSEcCtD
Mifepristone—NR3C1—FOXA2 and FOXA3 transcription factor networks—NKX2-1—hypothyroidism	0.00245	0.0231	CbGpPWpGaD
Mifepristone—Insomnia—Levothyroxine—hypothyroidism	0.00244	0.0134	CcSEcCtD
Mifepristone—Insomnia—Dextrothyroxine—hypothyroidism	0.00244	0.0134	CcSEcCtD
Mifepristone—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00241	0.0132	CcSEcCtD
Mifepristone—Dyspnoea—Levothyroxine—hypothyroidism	0.00241	0.0132	CcSEcCtD
Mifepristone—PGR—thyroid gland—hypothyroidism	0.00239	0.012	CbGeAlD
Mifepristone—Fatigue—Dextrothyroxine—hypothyroidism	0.00233	0.0128	CcSEcCtD
Mifepristone—Fatigue—Levothyroxine—hypothyroidism	0.00233	0.0128	CcSEcCtD
Mifepristone—PGR—female gonad—hypothyroidism	0.00231	0.0116	CbGeAlD
Mifepristone—AR—gonad—hypothyroidism	0.00226	0.0114	CbGeAlD
Mifepristone—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00222	0.0122	CcSEcCtD
Mifepristone—Feeling abnormal—Levothyroxine—hypothyroidism	0.00222	0.0122	CcSEcCtD
Mifepristone—Angioedema—Liotrix—hypothyroidism	0.00222	0.0122	CcSEcCtD
Mifepristone—AR—pituitary gland—hypothyroidism	0.00221	0.0111	CbGeAlD
Mifepristone—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00221	0.0121	CcSEcCtD
Mifepristone—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00221	0.0121	CcSEcCtD
Mifepristone—Urticaria—Levothyroxine—hypothyroidism	0.00214	0.0118	CcSEcCtD
Mifepristone—Urticaria—Dextrothyroxine—hypothyroidism	0.00214	0.0118	CcSEcCtD
Mifepristone—Body temperature increased—Levothyroxine—hypothyroidism	0.00213	0.0117	CcSEcCtD
Mifepristone—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00213	0.0117	CcSEcCtD
Mifepristone—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00213	0.0117	CcSEcCtD
Mifepristone—Abdominal pain—Levothyroxine—hypothyroidism	0.00213	0.0117	CcSEcCtD
Mifepristone—Hypertension—Liotrix—hypothyroidism	0.0021	0.0115	CcSEcCtD
Mifepristone—ABCC1—pituitary gland—hypothyroidism	0.0021	0.0105	CbGeAlD
Mifepristone—AR—Regulation of nuclear SMAD2/3 signaling—NKX2-5—hypothyroidism	0.00209	0.0198	CbGpPWpGaD
Mifepristone—NR3C1—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00208	0.0196	CbGpPWpGaD
Mifepristone—Arthralgia—Liotrix—hypothyroidism	0.00207	0.0114	CcSEcCtD
Mifepristone—Anxiety—Liotrix—hypothyroidism	0.00206	0.0113	CcSEcCtD
Mifepristone—PGR—testis—hypothyroidism	0.00205	0.0103	CbGeAlD
Mifepristone—PGR—Nuclear signaling by ERBB4—PRL—hypothyroidism	0.00199	0.0188	CbGpPWpGaD
Mifepristone—Oedema—Liotrix—hypothyroidism	0.00198	0.0109	CcSEcCtD
Mifepristone—NR3C1—adrenal cortex—hypothyroidism	0.00198	0.00995	CbGeAlD
Mifepristone—AR—adrenal gland—hypothyroidism	0.00197	0.00992	CbGeAlD
Mifepristone—AR—blood—hypothyroidism	0.00197	0.00992	CbGeAlD
Mifepristone—Infection—Liotrix—hypothyroidism	0.00197	0.0108	CcSEcCtD
Mifepristone—Asthenia—Levothyroxine—hypothyroidism	0.00194	0.0106	CcSEcCtD
Mifepristone—Asthenia—Dextrothyroxine—hypothyroidism	0.00194	0.0106	CcSEcCtD
Mifepristone—NR3C1—heart—hypothyroidism	0.00191	0.00962	CbGeAlD
Mifepristone—Pruritus—Levothyroxine—hypothyroidism	0.00191	0.0105	CcSEcCtD
Mifepristone—Pruritus—Dextrothyroxine—hypothyroidism	0.00191	0.0105	CcSEcCtD
Mifepristone—AR—thyroid gland—hypothyroidism	0.0019	0.00957	CbGeAlD
Mifepristone—Anorexia—Liotrix—hypothyroidism	0.00189	0.0104	CcSEcCtD
Mifepristone—PGR—cerebellum—hypothyroidism	0.00189	0.00951	CbGeAlD
Mifepristone—ABCC1—adrenal gland—hypothyroidism	0.00187	0.00942	CbGeAlD
Mifepristone—ABCC1—blood—hypothyroidism	0.00187	0.00942	CbGeAlD
Mifepristone—Hypotension—Liotrix—hypothyroidism	0.00185	0.0102	CcSEcCtD
Mifepristone—Diarrhoea—Levothyroxine—hypothyroidism	0.00185	0.0102	CcSEcCtD
Mifepristone—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00185	0.0102	CcSEcCtD
Mifepristone—AR—female gonad—hypothyroidism	0.00184	0.00925	CbGeAlD
Mifepristone—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00181	0.00995	CcSEcCtD
Mifepristone—ABCC1—thyroid gland—hypothyroidism	0.00181	0.00909	CbGeAlD
Mifepristone—NR3C1—cardiovascular system—hypothyroidism	0.00181	0.00908	CbGeAlD
Mifepristone—Insomnia—Liotrix—hypothyroidism	0.00179	0.00987	CcSEcCtD
Mifepristone—AR—Notch-mediated HES/HEY network—BGLAP—hypothyroidism	0.00177	0.0167	CbGpPWpGaD
Mifepristone—Dyspnoea—Liotrix—hypothyroidism	0.00177	0.00973	CcSEcCtD
Mifepristone—ABCC1—female gonad—hypothyroidism	0.00175	0.00878	CbGeAlD
Mifepristone—AR—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00174	0.0164	CbGpPWpGaD
Mifepristone—NR3C1—Endoderm Differentiation—NKX2-1—hypothyroidism	0.00173	0.0163	CbGpPWpGaD
Mifepristone—Decreased appetite—Liotrix—hypothyroidism	0.00173	0.00949	CcSEcCtD
Mifepristone—Vomiting—Dextrothyroxine—hypothyroidism	0.00172	0.00944	CcSEcCtD
Mifepristone—Vomiting—Levothyroxine—hypothyroidism	0.00172	0.00944	CcSEcCtD
Mifepristone—Fatigue—Liotrix—hypothyroidism	0.00171	0.00941	CcSEcCtD
Mifepristone—Rash—Dextrothyroxine—hypothyroidism	0.0017	0.00936	CcSEcCtD
Mifepristone—Rash—Levothyroxine—hypothyroidism	0.0017	0.00936	CcSEcCtD
Mifepristone—Dermatitis—Dextrothyroxine—hypothyroidism	0.0017	0.00935	CcSEcCtD
Mifepristone—Dermatitis—Levothyroxine—hypothyroidism	0.0017	0.00935	CcSEcCtD
Mifepristone—Constipation—Liotrix—hypothyroidism	0.0017	0.00934	CcSEcCtD
Mifepristone—Headache—Dextrothyroxine—hypothyroidism	0.00169	0.0093	CcSEcCtD
Mifepristone—Headache—Levothyroxine—hypothyroidism	0.00169	0.0093	CcSEcCtD
Mifepristone—NR3C1—gonad—hypothyroidism	0.00164	0.00824	CbGeAlD
Mifepristone—Feeling abnormal—Liotrix—hypothyroidism	0.00164	0.009	CcSEcCtD
Mifepristone—AR—testis—hypothyroidism	0.00163	0.0082	CbGeAlD
Mifepristone—Gastrointestinal pain—Liotrix—hypothyroidism	0.00162	0.00893	CcSEcCtD
Mifepristone—Nausea—Levothyroxine—hypothyroidism	0.0016	0.00882	CcSEcCtD
Mifepristone—Nausea—Dextrothyroxine—hypothyroidism	0.0016	0.00882	CcSEcCtD
Mifepristone—NR3C1—pituitary gland—hypothyroidism	0.0016	0.00804	CbGeAlD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—NKX2-5—hypothyroidism	0.00159	0.015	CbGpPWpGaD
Mifepristone—Urticaria—Liotrix—hypothyroidism	0.00158	0.00867	CcSEcCtD
Mifepristone—Body temperature increased—Liotrix—hypothyroidism	0.00157	0.00863	CcSEcCtD
Mifepristone—Abdominal pain—Liotrix—hypothyroidism	0.00157	0.00863	CcSEcCtD
Mifepristone—ABCC1—testis—hypothyroidism	0.00155	0.00779	CbGeAlD
Mifepristone—AR—liver—hypothyroidism	0.00154	0.00775	CbGeAlD
Mifepristone—PGR—Generic Transcription Pathway—ZNF764—hypothyroidism	0.0015	0.0141	CbGpPWpGaD
Mifepristone—ABCC1—liver—hypothyroidism	0.00146	0.00737	CbGeAlD
Mifepristone—Hypersensitivity—Liotrix—hypothyroidism	0.00146	0.00804	CcSEcCtD
Mifepristone—CYP3A5—blood—hypothyroidism	0.00144	0.00724	CbGeAlD
Mifepristone—ABCC1—cerebellum—hypothyroidism	0.00143	0.00719	CbGeAlD
Mifepristone—NR3C1—adrenal gland—hypothyroidism	0.00143	0.00718	CbGeAlD
Mifepristone—NR3C1—blood—hypothyroidism	0.00143	0.00718	CbGeAlD
Mifepristone—Asthenia—Liotrix—hypothyroidism	0.00142	0.00783	CcSEcCtD
Mifepristone—Pruritus—Liotrix—hypothyroidism	0.0014	0.00772	CcSEcCtD
Mifepristone—NR3C1—thyroid gland—hypothyroidism	0.00138	0.00693	CbGeAlD
Mifepristone—Diarrhoea—Liotrix—hypothyroidism	0.00136	0.00747	CcSEcCtD
Mifepristone—CYP3A5—female gonad—hypothyroidism	0.00134	0.00675	CbGeAlD
Mifepristone—PGR—Validated nuclear estrogen receptor alpha network—PRL—hypothyroidism	0.00134	0.0126	CbGpPWpGaD
Mifepristone—NR3C1—female gonad—hypothyroidism	0.00133	0.0067	CbGeAlD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00132	0.0124	CbGpPWpGaD
Mifepristone—Dizziness—Liotrix—hypothyroidism	0.00131	0.00722	CcSEcCtD
Mifepristone—Vomiting—Liotrix—hypothyroidism	0.00126	0.00694	CcSEcCtD
Mifepristone—Rash—Liotrix—hypothyroidism	0.00125	0.00688	CcSEcCtD
Mifepristone—Dermatitis—Liotrix—hypothyroidism	0.00125	0.00688	CcSEcCtD
Mifepristone—Headache—Liotrix—hypothyroidism	0.00124	0.00684	CcSEcCtD
Mifepristone—NR3C1—testis—hypothyroidism	0.00118	0.00594	CbGeAlD
Mifepristone—Nausea—Liotrix—hypothyroidism	0.00118	0.00648	CcSEcCtD
Mifepristone—AR—Generic Transcription Pathway—ZNF764—hypothyroidism	0.00114	0.0108	CbGpPWpGaD
Mifepristone—CYP3A5—liver—hypothyroidism	0.00113	0.00566	CbGeAlD
Mifepristone—AR—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00112	0.0106	CbGpPWpGaD
Mifepristone—NR3C1—liver—hypothyroidism	0.00112	0.00562	CbGeAlD
Mifepristone—NR3C1—cerebellum—hypothyroidism	0.00109	0.00549	CbGeAlD
Mifepristone—CYP3A4—blood—hypothyroidism	0.00108	0.00543	CbGeAlD
Mifepristone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—hypothyroidism	0.00107	0.0101	CbGpPWpGaD
Mifepristone—CYP2D6—blood—hypothyroidism	0.00106	0.00535	CbGeAlD
Mifepristone—ABCB1—adrenal cortex—hypothyroidism	0.00106	0.00533	CbGeAlD
Mifepristone—ABCB1—heart—hypothyroidism	0.00102	0.00515	CbGeAlD
Mifepristone—CYP2D6—female gonad—hypothyroidism	0.000991	0.00498	CbGeAlD
Mifepristone—AR—Coregulation of Androgen receptor activity—VAV3—hypothyroidism	0.000981	0.00926	CbGpPWpGaD
Mifepristone—ABCB1—cardiovascular system—hypothyroidism	0.000967	0.00486	CbGeAlD
Mifepristone—PGR—Generic Transcription Pathway—THRA—hypothyroidism	0.000964	0.0091	CbGpPWpGaD
Mifepristone—CYP2D6—testis—hypothyroidism	0.000879	0.00442	CbGeAlD
Mifepristone—ABCB1—gonad—hypothyroidism	0.000877	0.00441	CbGeAlD
Mifepristone—NR3C1—Generic Transcription Pathway—ZNF764—hypothyroidism	0.000865	0.00816	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—BGLAP—hypothyroidism	0.000861	0.00813	CbGpPWpGaD
Mifepristone—ABCB1—pituitary gland—hypothyroidism	0.000856	0.0043	CbGeAlD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00085	0.00802	CbGpPWpGaD
Mifepristone—CYP3A4—liver—hypothyroidism	0.000845	0.00425	CbGeAlD
Mifepristone—CYP2D6—liver—hypothyroidism	0.000831	0.00418	CbGeAlD
Mifepristone—CYP2D6—cerebellum—hypothyroidism	0.000812	0.00408	CbGeAlD
Mifepristone—NR3C1—Circadian Clock—AVP—hypothyroidism	0.000779	0.00735	CbGpPWpGaD
Mifepristone—ABCB1—adrenal gland—hypothyroidism	0.000765	0.00385	CbGeAlD
Mifepristone—ABCB1—blood—hypothyroidism	0.000765	0.00384	CbGeAlD
Mifepristone—ABCB1—thyroid gland—hypothyroidism	0.000738	0.00371	CbGeAlD
Mifepristone—AR—Generic Transcription Pathway—THRA—hypothyroidism	0.000735	0.00693	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—ZNF764—hypothyroidism	0.00072	0.0068	CbGpPWpGaD
Mifepristone—ABCB1—female gonad—hypothyroidism	0.000713	0.00359	CbGeAlD
Mifepristone—PGR—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.000687	0.00648	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—PRL—hypothyroidism	0.000671	0.00633	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—PRL—hypothyroidism	0.000635	0.00599	CbGpPWpGaD
Mifepristone—ABCB1—testis—hypothyroidism	0.000632	0.00318	CbGeAlD
Mifepristone—PGR—Generic Transcription Pathway—THRB—hypothyroidism	0.000621	0.00586	CbGpPWpGaD
Mifepristone—ABCB1—liver—hypothyroidism	0.000598	0.00301	CbGeAlD
Mifepristone—ABCB1—cerebellum—hypothyroidism	0.000584	0.00294	CbGeAlD
Mifepristone—NR3C1—Generic Transcription Pathway—THRA—hypothyroidism	0.000557	0.00526	CbGpPWpGaD
Mifepristone—AR—Gene Expression—ZNF764—hypothyroidism	0.000549	0.00518	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.000523	0.00494	CbGpPWpGaD
Mifepristone—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000476	0.00449	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—THRB—hypothyroidism	0.000473	0.00447	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—THRA—hypothyroidism	0.000464	0.00438	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000446	0.00421	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—ZNF764—hypothyroidism	0.000416	0.00393	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00041	0.00387	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.000397	0.00375	CbGpPWpGaD
Mifepristone—CYP3A7—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000386	0.00364	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—POMC—hypothyroidism	0.000376	0.00355	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—THRB—hypothyroidism	0.000359	0.00339	CbGpPWpGaD
Mifepristone—AR—Gene Expression—THRA—hypothyroidism	0.000354	0.00334	CbGpPWpGaD
Mifepristone—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000344	0.00325	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00034	0.00321	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000338	0.00319	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—NKX2-5—hypothyroidism	0.000331	0.00312	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—THRB—hypothyroidism	0.000299	0.00282	CbGpPWpGaD
Mifepristone—CYP3A5—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000279	0.00263	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—IYD—hypothyroidism	0.000277	0.00262	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—THRA—hypothyroidism	0.000268	0.00253	CbGpPWpGaD
Mifepristone—AR—Gene Expression—NKX2-5—hypothyroidism	0.000252	0.00238	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—IGF1—hypothyroidism	0.00025	0.00236	CbGpPWpGaD
Mifepristone—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000245	0.00231	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000242	0.00229	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—IYD—hypothyroidism	0.000242	0.00228	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—ATP5O—hypothyroidism	0.000236	0.00222	CbGpPWpGaD
Mifepristone—AR—Gene Expression—THRB—hypothyroidism	0.000228	0.00215	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—TPO—hypothyroidism	0.000222	0.00209	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ATP5O—hypothyroidism	0.000205	0.00194	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000205	0.00194	CbGpPWpGaD
Mifepristone—CYP3A7—Biological oxidations—POMC—hypothyroidism	0.000205	0.00193	CbGpPWpGaD
Mifepristone—CYP2D6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000198	0.00187	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000195	0.00184	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—TPO—hypothyroidism	0.000193	0.00182	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—NKX2-5—hypothyroidism	0.000191	0.0018	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—IYD—hypothyroidism	0.000175	0.00165	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—THRB—hypothyroidism	0.000173	0.00163	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CLTC—hypothyroidism	0.000171	0.00161	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000164	0.00155	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000162	0.00153	CbGpPWpGaD
Mifepristone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.00016	0.00151	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ATP5O—hypothyroidism	0.000149	0.0014	CbGpPWpGaD
Mifepristone—CYP3A5—Biological oxidations—POMC—hypothyroidism	0.000148	0.0014	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TRH—hypothyroidism	0.000147	0.00139	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—TPO—hypothyroidism	0.00014	0.00132	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—IYD—hypothyroidism	0.000132	0.00124	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TSHR—hypothyroidism	0.000131	0.00124	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TSHB—hypothyroidism	0.000131	0.00124	CbGpPWpGaD
Mifepristone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.00013	0.00122	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000129	0.00122	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—IYD—hypothyroidism	0.000124	0.00117	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—SH2B3—hypothyroidism	0.000117	0.00111	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ATP5O—hypothyroidism	0.000112	0.00106	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ATP5O—hypothyroidism	0.000106	0.000997	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—TPO—hypothyroidism	0.000105	0.000995	CbGpPWpGaD
Mifepristone—CYP2D6—Biological oxidations—POMC—hypothyroidism	0.000105	0.000994	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—TSHB—hypothyroidism	0.000103	0.000968	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—TPO—hypothyroidism	9.93e-05	0.000937	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	9.88e-05	0.000933	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3C2A—hypothyroidism	9.14e-05	0.000863	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	9.02e-05	0.000851	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—TSHB—hypothyroidism	8.94e-05	0.000844	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PRL—hypothyroidism	8.69e-05	0.00082	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—IYD—hypothyroidism	8.12e-05	0.000766	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PRL—hypothyroidism	8.1e-05	0.000764	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—VAV3—hypothyroidism	8.04e-05	0.000758	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3C2A—hypothyroidism	7.97e-05	0.000752	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	7.8e-05	0.000736	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—AVP—hypothyroidism	7.74e-05	0.000731	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—SLC5A5—hypothyroidism	7.68e-05	0.000725	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ATP5O—hypothyroidism	6.91e-05	0.000652	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—POMC—hypothyroidism	6.88e-05	0.00065	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—SLC5A5—hypothyroidism	6.7e-05	0.000632	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—TPO—hypothyroidism	6.49e-05	0.000613	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—TSHB—hypothyroidism	6.47e-05	0.00061	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	6.14e-05	0.000579	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3C2A—hypothyroidism	5.76e-05	0.000544	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—POMC—hypothyroidism	5.15e-05	0.000486	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IGF1—hypothyroidism	4.95e-05	0.000467	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—TSHB—hypothyroidism	4.88e-05	0.00046	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—SLC5A5—hypothyroidism	4.84e-05	0.000457	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—TSHB—hypothyroidism	4.6e-05	0.000434	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3C2A—hypothyroidism	4.35e-05	0.00041	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	4.1e-05	0.000387	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—POMC—hypothyroidism	4.02e-05	0.000379	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—SLC5A5—hypothyroidism	3.65e-05	0.000345	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—POMC—hypothyroidism	3.5e-05	0.000331	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—SLC5A5—hypothyroidism	3.44e-05	0.000325	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—TSHB—hypothyroidism	3.01e-05	0.000284	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	2.68e-05	0.000253	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—POMC—hypothyroidism	2.53e-05	0.000239	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SLC5A5—hypothyroidism	2.25e-05	0.000212	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—POMC—hypothyroidism	1.91e-05	0.00018	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—POMC—hypothyroidism	1.8e-05	0.00017	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—POMC—hypothyroidism	1.18e-05	0.000111	CbGpPWpGaD
